Recent Company News

• 07:34 AM ET Dec 11, 2025
  

  Rhythm announces preliminary data from exploratory Phase 2 Trial showing Setmelanotide demonstrated positive efficacy signal in Prader-Willi Syndrome ($104.77, 0.00)

• 01:11 AM ET Dec 11, 2025
  

  European Patent Office intends to grant a new patent for IRLAB's mesdopetam. (SEK 1.98, 0.00)

• 04:02 PM ET Dec 10, 2025
  

  Rhythm Pharmaceuticals to announce preliminary data on 11-Dec from exploratory Phase 2 Trial evaluating setmelanotide in Prader-Willi syndrome ($104.77, 0.00)

• 01:07 AM ET Dec 05, 2025
  

  Ipsen confirms Beaufour's Beech Tree share transfer to Alasol Foundation (€122.40, 0.00)

• 01:01 AM ET Dec 01, 2025
  

  Ipsen mourns the passing of Henri Beaufour (26% holder), founding family board member (€124.30, 0.00)

• 07:53 PM ET Nov 26, 2025
  

  StreetAccount Sector Summary - Healthcare Weekly Recap

• 08:31 AM ET Nov 26, 2025
  

  StreetAccount Sector Summary - Healthcare Pre-Market

• 01:09 AM ET Nov 26, 2025
  

  Ipsen downgraded to underperform from neutral at BNP Paribas Exane (€128.10, 0.00)

• 09:03 AM ET Nov 21, 2025
  

  FDA confirms the marketing withdrawal of Ocaliva (obeticholic acid) NDA and three related generics

• 04:08 AM ET Nov 12, 2025
  

  StreetAccount Summary: EU stocks reaching new 52-week highs/lows (105 total)